Public Policy

One of the Alliance’s most important missions is to advocate for aging research by working with legislators, health experts and other like-minded organizations. Our public policy efforts are summarized here.

Press Room

Alliance for Aging Research Approved for a Eugene Washington Engagement Award by the Patient-Centered Outcomes Research Institute

Author: Noel Lloyd

Date: October 27th, 2016

The Alliance for Aging Research (Alliance) announced today that it has been approved for a $250,000 Eugene Washington PCORI Engagement Award to create a first-ever Senior Patient and Family Caregiver Network (SP&FCN) by the Patient-Centered Outcomes Research Institute (PCORI). 

Publications

Blog

Senior Patient and Family Caregiver Network Holds First Advocate Mentor Training

Author: Noel Lloyd

Date: June 22nd, 2017

On May 23 and 24 in Washington, D.C., the Senior Patient and Family Caregiver Network held its first-ever training session for its patient and family caregiver advocates. 


CER for More Patient-Centered Care

Author: Cynthia Bens

Date: May 23rd, 2014

Type: Blog

There is increasing emphasis on shaping a system that makes optimal patient outcomes a priority. The Alliance has been paying close attention to Patient-Centered Outcomes Research Institute’s (PCORI) initial work to provide information on which treatments and technologies deliver the best results. 


Turning a Blind Eye on Patients

Author: Cynthia Bens

Date: May 22nd, 2014

Type: Blog

Alliance Vice President of Public Policy Cynthia Bens discusses AMD and older adults. 


Challenges and Opportunities for PCORI and CER

Author: Guest Contributor

Date: January 30th, 2012

In a time of skyrocketing health care costs, both the private and public sectors struggle to balance economics with access to high quality health care. Evidence from comparative effectiveness research (CER) and “head-to-head” clinical trials is increasingly being used in health care treatment decision-making around the globe, but how will this affect access to quality care? More importantly, where will the public draw the line between cost and access?


Moving Along the Guiderails with CER

Author: Lindsay Clarke

Date: December 15th, 2011

In a time where health care spending is sky-rocketing, where will the public draw the line? Evidence from comparative effectiveness research (CER) is increasingly being used in health-care treatment decision-making around the globe, yet there is still a lot to be learned about how the public feels and where they think the lines should be drawn.

Newsletter

Treatments for Age-Related Macular Degeneration: Going Head to Head

Date: May 1st, 2011

Exciting treatments make slowing and even restoring vision loss in wet age-related macular degeneration (wAMD) patients a reality. Two of the most frequently used treatments are currently in the spotlight as they go head-to-head in clinical trials comparing their effectiveness, and to some extent, exploring their costs.


Empowering Patients with Information and Improving Care

Date: March 1st, 2008

No one can deny that our country’s health care spending is reaching an unmanageable level. In 2006 we spent over $2 trillion on health care and some experts predict that we’ll be spending twice that much by 2017. While you might assume that population growth is causing these increases—more people usually means more health care—we’re also seeing a rise in the amount of money that we spend on each person.

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It